YS
Therapeutic Areas
Orasis Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Qlosi™ | Presbyopia | Approved |
Leadership Team at Orasis Pharmaceuticals
EK
Elad Kedar
Chief Executive Officer
PS
Paul Smith
President and Chief Operating Officer
JS
Julie Speed
Senior Vice President, Marketing and Commercial Operations
JF
Jeff Francis
Vice President, Sales
RN
Ron Neumann, M.D.
Chief Medical Officer
IM
Ignacio, M.D.
Vice President, Medical Affairs
SA
Sharon Amzel‑Sasson
Vice President, Pharmaceutical Development and Manufacturing
IM
Iris Meisner
Head of Regulatory Affairs
SF
Sam Fakhoury
Vice President, Quality and Operations